showed a trendP = 0.083
It also showed a trend of lower pathological tumor stage (pT1-2: 26.4% vs 19.1%, P = 0.083) and lower pathological nodal stage (pN0: 60.4% vs 52.7%, P = 0.079) (Table 3 ).
It also showed a trend of lower pathological tumor stage (pT1-2: 26.4% vs 19.1%, P = 0.083) and lower pathological nodal stage (pN0: 60.4% vs 52.7%, P = 0.079) (Table 3 ).